XLRN logo
Acceleron Pharma Inc.(XLRN)
$178.75—Stale · unknown old

Trailing Twelve Months (TTM) Metrics

Per Share (TTM)
Revenue/Share$1.63
Net Income/Share$-2.92
Operating CF/Share$-2.29
Free CF/Share$-2.37
Cash/Share$14.96
Book Value/Share$15.05
Tangible Book/Share$15.05
Equity/Share$15.05
Interest Debt/Share$0.42
CapEx/Share$0.07
Dividend/Share$0.00
Valuation (TTM)
Market Cap--
Enterprise Value-$646.88M
P/E Ratio-61.22P/S Ratio0.00
P/OCF Ratio-77.90
P/FCF Ratio0.00
P/B Ratio11.87
P/TB Ratio11.87
EV/Sales-6.99
EV/EBITDA3.96
Graham Valuation
Graham Number--
Graham Net-Net$13.95
Profitability (TTM)
Earnings Yield-1.64%FCF Yield--ROE-25.45%ROIC-19.03%Return on Tangible Assets-17.81%
Dividend (TTM)
Dividend Yield0.00%Payout Ratio0.00%
Capital Allocation
CapEx/OCF-3.22%
CapEx/Revenue4.54%
CapEx/Depreciation1.09
SBC/Revenue32.68%
SG&A/Revenue0.00%
R&D/Revenue187.97%
Liquidity & Solvency
Debt/Equity0.03Debt/Assets0.03
Debt/Market Cap--
Net Debt/EBITDA3.96
Current Ratio14.85Interest Coverage0.00xIncome Quality0.78
Efficiency
Days Sales Outstanding103 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover3.54x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$855.11M
Working Capital$833.11M
Invested Capital$862.86M
Intangibles/Assets0.00%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.